Navigation Links
NeurogesX Reports Third Quarter 2009 Results
Date:11/6/2009

ch related initiatives, including:

  • Significant management additions to U.S. commercial team: VP Sales; Senior Director, Marketing; and Director, Commercial Operations
  • Market research updates to support launch planning and sales force sizing
  • Continued pursuit of our desired reimbursement scenarios for Qutenza

The Company expects to provide an update and additional details on U.S. commercialization plans once it learns the outcome of the FDA review of Qutenza in PHN.

In late September 2009, the Company completed the transfer of the Qutenza Marketing Authorization (MA) to Astellas, which is now the legal holder of the MA. In accordance with the licensing agreement between NeurogesX and Astellas, the MA transfer supports the E.U. launch of Qutenza for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. As a result of the MA transfer, Astellas is now responsible for ongoing maintenance of the MA, including certain post-marketing commitments for a safety and efficacy study of Qutenza.

In addition to Qutenza launch preparation activities, the Company appointed Bradford S. Goodwin to its Board of Directors as a director and Audit Committee chairman. Mr. Goodwin is currently President and CEO of Keren Pharmaceutical, nonexecutive chairman of Facet Biotech Corp. and a director of Rigel, Inc. He is a healthcare industry veteran that has held various senior executive positions at Novacea, Inc., Collabra Pharma, and Genentech, Inc.

Anthony DiTonno, President and CEO, commented, "The NeurogesX team continues to operate at exceptional levels as our focus remains squarely fixed on the upcoming PDUFA date for the potential U.S. approval of Qutenza in PHN. During the third quarter our commercialization readiness activities for Qutenza took center stage. Turning towards the E.U. launch, our highly collaborative and posit
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. NeurogesX to Present at Two November Conferences
2. NeurogesX to Present at UBS Global Life Sciences Conference
3. NeurogesX to Present at Upcoming Fall Conferences
4. NeurogesX Appoints New Board Director and Audit Committee Chairman
5. NeurogesX Reports Second Quarter 2009 Results
6. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
7. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
8. NeurogesX Added to Russell 3000 Index
9. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
10. NeurogesX to Present at Needham Life Sciences Conference
11. NeurogesX Receives European Commission Approval for Qutenza(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),...odaythatitexecuted,ajointventure(JV)agreementtoest...novacDalian).TheJVwillresearch,develop,produce,and...teitsexpertise,andexperienceindevelopingandcommerc...gitslanduserights,manufacturingfacilitiesand,estab...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ..., , ,Who: David Appia, French Ambassador for Inter...nvest in France Agency, , , , ,What: Ambassador A...cent pro-business initiatives adopted by France to...c landscape for innovation and development., , ,Wh...
(Date:11/24/2009)...S,Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCorpo...XconferenceonTuesday,December1stat1:45PMGMTinLondo...diobroadcastovertheInternetavailableat http://inv...kthe"Webcast"icontoaccessthisfile. ,, AboutSi...dHighTechnologycompany.Itschemicalandbiochemicalpr...
(Date:11/24/2009)...I,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounce...hasapprovedthe,investigationalnewdrugapplication(I...nsulinformulationtotreatdiabetes.ThisIND,approvala... , Diabetesisadisordercharacteristicofhighblo...etesoftenresultinseveremicro-and,macro-vasculardis...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... Inc. (Nasdaq: BMRN ) today announced that Joshu...Development of BioMarin, will present a company up...go on Thursday, May 14, 2009 at 10:40 a.m. CT. ,...cast of the conference call via the investor secti...eplay of the call will be archived on the site for...
..., Inc.,(Nasdaq: DCGN ) today announced that it wi... in a press release to be issued on Monday, May 11...ompany will host a live webcast of,its conference ... highlights,on Tuesday, May 12, at 8am Eastern Day... The webcast can be accessed through the Investor...
...CVD ) announced that it has elected John McCartney...rrently serves as chairman of the board of A.M. Ca..., services, and supply chain solutions. He was fo...S. Robotics (USR), a multibillion dollar provider ...r executive in the management team that grew USR f...
Other Biology Technology:BioMarin to Present at the Baird Growth Stock Conference 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results 2Covance Elects John McCartney to Company's Board of Directors 2
(Date:11/24/2009)...tute (LRI) today named 12 new grant recipients for...e innovative work across a broad spectrum of lupus... novelty, and potential to drive scientific discov...plex disease of systemic lupus. , The 2009 grant... across the nation and include interdisciplinary a...
(Date:11/24/2009)...of a remarkable class of ring-shaped protein motor...nce Berkeley National Laboratory (Berkeley Lab) us...mline at the Advanced Light Source (ALS). These pr... and replication, and are vital to the survival of...s, such as the human papillomavirus, which has bee...
(Date:11/24/2009)...ood is a matter of debate. A high-profile study a ...rcent of their carbon from trees and leaves, evide...and aquatic ecosystems. , But new research from ...ely to be true. Algae provide a much richer diet f...rch published this week in the Proceedings of the...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3ReBuilder Medical Technologies Inc Announces Negotiations with National Medicare Provider 55610 1ReBuilder Medical Technologies Inc Announces Negotiations with National Medicare Provider 55610 2SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies 13731 1SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies 13731 2Missouri Families Demand Representative Blunt to Stop Playing Politics With Healthcare Reform 55604 1Missouri Families Demand Representative Blunt to Stop Playing Politics With Healthcare Reform 55604 2Missouri Families Demand Representative Blunt to Stop Playing Politics With Healthcare Reform 55604 3
...gning something, its hard to find a better source ...nciple, a diverse, interdisciplinary group of rese...oratory is mimicking bacteria to synthesize magnet...ting and delivery, in magnetic inks and high-dens.... , Commercial room-temperature synthesis of ferr...
...e debate is familiar to most people, and modern co...o. A new paper published this week in the open-acc...ilar balance between the genes we inherit—nature—a...s of traits in yeast. As we approach the age of pe...ng about the genetic variations we carry, it is im...
...riations ensure that no two people are exactly ali...e tools and the knowledge to predict how individua...recise and effective treatment. At the 2008 Annual...search, April 12 16, researchers present data on ...nown treatments for breast cancer, pediatric neuro...
Other Biology News:Researchers mimic bacteria to produce magnetic nanoparticles 2Researchers mimic bacteria to produce magnetic nanoparticles 3Biomarkers allow doctors to match therapy to patient 2Biomarkers allow doctors to match therapy to patient 3Biomarkers allow doctors to match therapy to patient 4Biomarkers allow doctors to match therapy to patient 5Biomarkers allow doctors to match therapy to patient 6Biomarkers allow doctors to match therapy to patient 7
Cover Glasses from Santa Cruz Biotechnology, Inc.
G-Protein Coupled Receptor Assay from GE Healthcare, formerly Amersham Biosciences
Amino acid mixture excluding l-[U-14C]methionine from GE Healthcare, formerly Amersham Biosciences
Spheroplast Kit for Yeast from Invitrogen
Biology Products: